CD34 and central nervous system cancer: Although CD34 is a marker of vascular endothelial progenitor cells (29, 30) and an optimal marker of microvascular density, a recent study showed that CD34 overexpression was associated with higher WHO glioma grades (III + IV) in 684 patients, suggesting that CD34 is a potential diagnostic and prognostic marker and therapeutic target for gliomas (31).